Patient satisfaction in diabetes mellitus - Measures and results;Patientenzufriedenheit bei diabetes mellitus - Messinstrumente und ergebnisse

Deutsche Medizinische Wochenschrift

Volumn 133, Issue 34-35 SUPPL. 4, 2008, Pages

  Kohlmann, Thomas ^a   Moock, J ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Insulin glargine; Insulin treatment; NPH insulin; Patient satisfaction; Quality of life

Indexed keywords

INSULIN; INSULIN GLARGINE; ISOPHANE INSULIN; ANTIDIABETIC AGENT; DRUG DERIVATIVE; GLARGINE;

CLINICAL STUDY; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PSYCHOMETRY; QUALITY OF LIFE; REVIEW; RISK FACTOR; HEALTH STATUS; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; TREATMENT OUTCOME;

DIABETES MELLITUS, TYPE 2; HEALTH STATUS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 50349083483     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1081106     Document Type: Review

References (10)

1. Aaronson NK, Ahmedzai S, Bergman B et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-376
2. Bradley C. The Diabetes Treatment Satisfaction Questionnaire: DTSQ.In: Bradley C, editor (Hrsg). Handbook of Psychology and Diabetes: a guide to psychological measurement in diabetes research and practice. Chur, Switzerland: Harwood Academic Publishers, 1994: 111-132
3. Bullinger M. Trends in der internationalen Lebensqualitä tsforschung.In: Petermann F, editor (Hrsg). Lebensqualität und chronische Krankheit. München: Dustri-Verlag, 1996: 5-28
4. Bullinger M, Kirchberger I. SF-36. Fragebogen zum Gesundheitszustand. Handanweisung. Göttingen: Hogrefe, 1998
5. Dingler D, Moock J, Kubiak T, Kohlmann T. ITEQ - Ein neues Instrument zur Erfassung der Therapiezufriedenheit bei Patienten mit Diabetes mellitus Typ 2 unter Insulinbehandlung. Diabet. u. Stoffwechsel 2007; 2: P194
6. Food and Drug Administration (FDA). Guidance for Industry. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims (Draft Guidance). Rockville, MD: 2006
7. Gray JA. Evidence-based healthcare. Edinburg: Churchill Livingstone, 1997
8. Moock J, Kubiak T, Dingler D, Kohlmann T. Comparisons between ITEQ and DTSQ in a sample of type 2 diabetes mellitus patients. Value in Health 2007; 10 (6): A278-A279
9. Polonsky WH, Anderson BJ, Lohrer PA, Welch G, Jacobson AM, Aponte JE, Schwartz CE. Assessment of diabetes-related distress. Diabetes Care 1995; 18 (6): 754-760
10. Schmidt CO, Hastedt C, Anderson-Hillemacher A et al. Zufriedenheit chronischer Schmerzpatienten mit ihrer analgetischen Medikation. Schmerz 2006; 20: 69-78